Cancer patients get extended access to promising drug in safety Follow-Up
NCT ID NCT03844048
Summary
This study allows patients already receiving venetoclax in other trials to continue treatment if they are benefiting and tolerating it well. The main goal is to collect long-term safety information by tracking any side effects. It includes about 165 patients with various blood cancers like leukemia and lymphoma.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LYMPHOBLASTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Aarhus Universitetshospital - Skejby /ID# 224214
Aarhus, Central Jutland, 8200, Denmark
-
Ankara Univ Medical Faculty /ID# 225043
Ankara, 06590, Turkey (Türkiye)
-
Aotearoa Clinical Trials /ID# 225596
Papatoetoe, Auckland, 2025, New Zealand
-
Beaumont Hospital /ID# 225165
Dublin, D09 XR63, Ireland
-
Blackpool Teaching Hospitals NHS Foundation Trust /ID# 225163
Blackpool, FY3 8NR, United Kingdom
-
CHU Grenoble - Hopital Michallon /ID# 240497
La Tronche, Isere, 38700, France
-
CHUQ- Hôpital de l'Enfant-Jesus /ID# 224616
Québec, Quebec, G1J 1Z4, Canada
-
Centro de Investigacion Clínica Chapultepec SA de CV /ID# 227018
Morelia, Michoacán, 58260, Mexico
-
China Medical University Hospital /ID# 224945
Taichung, 40447, Taiwan
-
Clatterbridge Cancer Centre - Liverpool /ID# 218736
Liverpool, L7 8YA, United Kingdom
-
Cliniques Universitaires UCL Saint-Luc /ID# 224327
Brussels, Brussels Capital, 1200, Belgium
-
Dana-Farber Cancer Institute /ID# 215360
Boston, Massachusetts, 02215, United States
-
Dartmouth-Hitchcock Medical Center /ID# 210555
Lebanon, New Hampshire, 03756, United States
-
Derriford Hospital and the Royal Eye Infirmary /ID# 218731
Plymouth, Devon, PL6 8DH, United Kingdom
-
Duplicate_Medizinische Universitaet Graz /ID# 223817
Graz, Styria, 8010, Austria
-
Duplicate_National Hospital Organization Mito Medical Center /ID# 241986
Higashi Ibaraki-gun, Ibaraki, 311-3193, Japan
-
Duplicate_Okayama Medical Center /ID# 241517
Okayama, Okayama-ken, 701-1192, Japan
-
Duplicate_Pratia MCM Krakow /ID# 218561
Krakow, Lesser Poland Voivodeship, 30-727, Poland
-
Duplicate_Skane University Hospital Lund /ID# 224747
Lund, Skåne County, 221 41, Sweden
-
Federal State Budgetary Scientific Institution N.N. Blokhin /ID# 225194
Moscow, Moscow, 115478, Russia
-
Fiona Stanley Hospital /ID# 239480
Murdoch, Western Australia, 6150, Australia
-
General Hospital of Athens Laiko /ID# 224087
Athens, Attica, 11527, Greece
-
General Hospital of Thessaloniki George Papanikolaou /ID# 224088
Thessaloniki, 57010, Greece
-
HCL - Hopital Lyon Sud /ID# 213508
Pierre-Bénite, Rhone, 69495, France
-
Hospital Universitario Dr. Jose Eleuterio Gonzalez /ID# 227017
Monterrey, Nuevo León, 64460, Mexico
-
Hospital Universitario Fundacion Jimenez Diaz /ID# 225476
Madrid, 28040, Spain
-
IPO Lisboa FG, EPE /ID# 225072
Lisbon, 1099-023, Portugal
-
Ingalls Memorial Hosp /ID# 210553
Harvey, Illinois, 60426, United States
-
Instytut Hematologii i Transfuzjologii /ID# 225478
Warsaw, Masovian Voivodeship, 02-776, Poland
-
Istanbul University Istanbul Medical Faculty /ID# 225045
Istanbul, 34093, Turkey (Türkiye)
-
Kings College Hospital NHS Foundation Trust /ID# 218735
London, Greater London, SE5 9RS, United Kingdom
-
Kobe City Medical Center General Hospital /ID# 241518
Kobe, Hyōgo, 650-0047, Japan
-
Leicester Royal Infirmary /ID# 240468
Leicester, England, LE1 5WW, United Kingdom
-
Liverpool Hospital /ID# 225591
Liverpool, New South Wales, 2170, Australia
-
Municipal Non-Profit Enterprise City Clinical Hospital 4 of Dnipro City Council /ID# 240575
Dnipro, 49102, Ukraine
-
National Cancer Center Hospital /ID# 241516
Chuo-ku, Tokyo, 104-0045, Japan
-
National Taiwan University Hospital /ID# 224946
Taipei City, Taipei, 100, Taiwan
-
North Shore Hospital /ID# 225597
Takapuna, Auckland, 0622, New Zealand
-
Perth Blood Institute Ltd /ID# 225592
Nedlands, Western Australia, 6009, Australia
-
Peter MacCallum Cancer Ctr /ID# 210559
Melbourne, Victoria, 3000, Australia
-
Queen Mary Hospital /ID# 224944
Hong Kong, 999077, Hong Kong
-
Regional Oncological Dispensary /ID# 225195
Penza, Penza Oblast, 440071, Russia
-
Rigshospitalet /ID# 224213
Copenhagen Ø, Capital Region, 2100, Denmark
-
Royal Prince Alfred Hospital /ID# 239557
Camperdown, New South Wales, 2050, Australia
-
SP ZOZ Zespol Szpitali Miejskich w Chorzowie /ID# 225474
Chorzów, Silesian Voivodeship, 41-500, Poland
-
Samsung Medical Center /ID# 240882
Seoul, Seoul Teugbyeolsi, 06351, South Korea
-
St George Hospital /ID# 225589
Kogarah, New South Wales, 2217, Australia
-
Swedish Medical Center - Seattle /ID# 213120
Seattle, Washington, 98104, United States
-
The Royal Wolverhampton NHS Trust /ID# 225164
Wolverhampton, WV10 0QP, United Kingdom
-
UCLA Santa Monica Hematology Oncology /ID# 210551
Los Angeles, California, 90095, United States
-
University College London Hospital /ID# 240467
London, Greater London, NW1 2BU, United Kingdom
-
University Hospital Southampton NHS Foundation Trust /ID# 225161
Southampton, Hampshire, SO16 6YD, United Kingdom
-
University of Arizona Cancer Center - Tucson /ID# 210548
Tucson, Arizona, 85724, United States
-
University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 231132
Ann Arbor, Michigan, 48109, United States
-
Vehbi Koc vakfi Amerikan Hasta /ID# 225046
Istanbul, 34365, Turkey (Türkiye)
-
Wellington Regional Hospital /ID# 225593
Newtown, Wellington Region, 6021, New Zealand
Conditions
Explore the condition pages connected to this study.